SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, both dates inclusive (the “Class Period”), have until Monday, March 9, 2026 to seek appointment as lead plaintiff of the Ardent Health class action lawsuit. Captioned Postiwala v. Ardent Health, Inc., No. 26-cv-00022 (M.D. Tenn.), the Ardent Health class action lawsuit charges Ardent Health and certain ...

New York, New York--(Newsfile Corp. - February 10, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-hea ...

Group 1 - The article discusses multiple shareholder class action lawsuits against Fermi Inc., Ardent Health, and Varonis Systems, alleging misleading statements and failure to disclose material facts [1][2][3] - Fermi Inc. is accused of failing to disclose material facts regarding tenant demand for its Project Matador campus between October 1, 2025, and December 11, 2025 [1] - Ardent Health is alleged to have made misleading statements about the collectability of its accounts receivable from July 18, 2024, to November 12, 2025 [2] - Varonis Systems is facing allegations related to its ability to convert its existing customer base and its ARR growth potential between February 4, 2025, and October 28, 2025 [3] Group 2 - The deadlines for investors to seek appointment as lead plaintiffs in these cases are March 6, 2026, for Ardent Health and March 9, 2026, for Varonis Systems [2][3] - Holzer & Holzer, LLC is a law firm specializing in securities litigation, having recovered hundreds of millions of dollars for shareholders affected by corporate misconduct since its founding in 2000 [4]

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-ac ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ardent Health, Inc. for alleged violations of federal securities laws related to misleading statements about the company's accounts receivable and malpractice liability insurance [2][4]. Group 1: Legal Investigation - The firm is encouraging investors who suffered losses exceeding $50,000 from purchasing Ardent securities between July 18, 2024, and November 12, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Ardent, with a deadline of March 9, 2026, for investors to seek the role of lead plaintiff [2][4]. - The complaint alleges that Ardent and its executives made false statements and failed to disclose critical information regarding the company's financials [4]. Group 2: Company Background - Ardent Health, Inc. is publicly traded on the NYSE under the ticker ARDT [2]. - The firm, Faruqi & Faruqi, has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. Group 3: Call for Information - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding Ardent's conduct [5].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a focus on the collection of accounts receivable [4]. - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while actually using a "180-day cliff" method for reserving accounts [4]. - This misrepresentation allegedly allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million decrease in revenue for the quarter and increased its professional liability reserves by $54 million, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 per share [5].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a critical focus on the collection of accounts receivable [4]. - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections" while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million decrease in revenue for the quarter and increased its professional liability reserves by $54 million due to adverse claim developments [5]. - Following this announcement, Ardent Health's stock price dropped by $4.75 per share, or over 33%, from $14.05 to $9.30 per share [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The Class Period for the Ardent Health securities is from July 18, 2024, to November 12, 2025 [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by March 9, 2026, to serve as lead plaintiff [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [3] Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable and the processes for determining collectability [4] - Defendants claimed to employ an active monitoring process for accounts receivable, which was later revealed to be inaccurate, as they utilized a 180-day cliff for reserving accounts [4] - The firm also misrepresented its professional malpractice liability insurance coverage, which was insufficient to cover claims arising from operations [4]

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose information regarding Ardent Health's accounts receivable. During the Class Period, Def ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Ardent Health operates acute care hospitals and other healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Fraud - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method that inflated reported accounts receivable and delayed loss recognition [4]. Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 on November 13, 2025 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, with the case titled Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. Law Firm Background - Bleichmar Fonti & Auld LLP, the law firm representing the plaintiffs, is recognized for its success in securities class actions and has recovered significant amounts for clients in past cases [7].